News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
109–127
Matches
127
Sources here
13
Companies here
3
Search results Stored financial headlines

Active search

127 matching headlines

Ticker or company: NCYTMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Incyte Corp. stock underperforms Thursday when compared to competitors despite daily gains

Incyte Corp. (INCY) shares gained 1.36% on Thursday, closing at $116.65, marking its third consecutive day of increases despite an overall negative trading session for the broader market. The S&P 500 and Dow Jones Industrial Average both experienced declines. However, Incyte's stock still underperformed …

INCY main company
Sharemaestro market context Trend signal active 52 weeks +41.3% INCY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What Do the Povorcitinib Trial Results Mean for Incyte

Incyte's Povorcitinib has shown strong long-term efficacy and a manageable safety profile in late-stage trials for moderate-to-severe Hidradenitis Suppurativa (HS), positioning it as a potential first-in-class oral treatment. The HS market represents a significant unmet need, offering a substantial new revenue stream for Incyte. …

INCY main company
Sharemaestro market context Trend signal active 52 weeks +41.3% INCY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Incyte’s 11.5M-share rebound resets the recovery debate near a 52-week high

INCY rallied 15.8% for the week and closed at $113.8, only 1.6% below its 52-week high, but the weekly Trend Signal remains inactive and Fair Value distance is stretched.

INCY main company
Sharemaestro market context Trend signal active 52 weeks +41.3% INCY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context